WealthOne’s Elevance Health ELV Stock Holding History

WealthOne’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$457K	Sell	1,050 -1	-0.1%	-$454	0.18%	46
2023 Q2	$467K	Buy	1,051 +8	+0.8%	+$3.69K	0.17%	53
2023 Q1	$480K	Buy	1,043 +3	+0.3%	+$1.43K	0.19%	53
2022 Q4	$533K	Buy	1,040 +3	+0.3%	+$1.52K	0.22%	52
2022 Q3	$471K	Buy	1,037 +1	+0.1%	+$478	0.2%	57
2022 Q2	$500K	Buy	1,036 +5	+0.5%	+$2.47K	0.2%	56
2022 Q1	$507K	Buy	1,031 +2	+0.2%	+$914	0.18%	63
2021 Q4	$477K	Buy	1,029 +3	+0.3%	+$1.26K	0.16%	63
2021 Q3	$382K	Hold	1,026	–	–	0.14%	78
2021 Q2	$392K	Buy	+1,026	New	+$392K	0.15%	76
2019 Q1	–	Sell	-19	Closed	-$5K	–	202
2018 Q4	$5K	Buy	+19	New	+$5.22K	﹤0.01%	456

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

WealthOne's ELV Position: Q3 2023 in Review

WealthOne reduced its Elevance Health (ELV) stake by 0.1% in Q3 2023, selling an estimated $454 and leaving 1,050 shares worth $457K. The position accounts for 0.18% of the portfolio, ranked #46.

WealthOne first reported a position in ELV in Q4 2018 and has held it in 11 quarters since. The position peaked at $533K in Q4 2022. 1,525 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

WealthOne held 1,050 shares of Elevance Health worth $457K as of Q3 2023.
WealthOne sold 1 Elevance Health share in Q3 2023, an estimated $454.
Elevance Health made up 0.18% of WealthOne's portfolio in Q3 2023, its #46 holding.
WealthOne first reported a position in Elevance Health in Q4 2018 and has held it in 11 quarters since.
WealthOne's Elevance Health position peaked at $533K in Q4 2022.
1,525 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on WealthOne's 13F filing for Q3 2023, filed 12 Oct 2023.